What is TransAct Technologies' operating income?

TransAct Technologies' total operating income in 2025 was -$1.42 million, based on the following breakdown: Total Gross Profit: $25.02 million Total Operating Expenses: $26.43 million

TransAct Technologies (TACT) Financials

$5.18 -0.13 (-2.45%)

Closing price 07/16/2026 04:00 PM Eastern

Extended Trading

$5.19 +0.01 (+0.19%)

As of 07/16/2026 04:15 PM Eastern

Compare

Annual Income Statements for TransAct Technologies

This table shows TransAct Technologies' income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Net Income / (Loss) Attributable to Common Shareholders	3.09	3.62	3.21	5.43	0.52	-5.63	-4.04	-5.94	4.75	-9.86	-1.24
Consolidated Net Income / (Loss)	3.09	3.62	3.21	5.43	0.52	-5.63	-4.04	-5.94	4.75	-9.86	-1.24
Net Income / (Loss) Continuing Operations	3.09	3.62	3.21	5.43	0.52	-5.63	-4.04	-5.94	4.75	-9.86	-1.24
Total Pre-Tax Income	4.44	5.17	6.77	6.47	0.37	-8.17	-6.08	-7.90	5.90	-3.57	-1.08
Total Operating Income	4.47	5.20	6.81	6.76	0.34	-8.17	-9.38	-7.68	5.71	-3.63	-1.42
Total Gross Profit	25	24	27	27	22	13	15	24	38	21	25
Total Revenue	60	57	56	55	46	31	39	58	73	43	51
Operating Revenue	60	57	56	55	46	31	39	58	73	43	51
Total Cost of Revenue	35	33	30	28	24	18	24	34	34	22	26
Operating Cost of Revenue	35	33	30	28	24	18	24	34	34	22	26
Total Operating Expenses	21	19	20	20	22	21	25	32	33	25	26
Selling, General & Admin Expense	7.37	7.27	7.98	8.21	9.17	9.26	9.63	12	13	9.94	11
Marketing Expense	7.81	6.91	7.56	7.20	8.03	6.14	7.66	11	9.93	8.20	8.43
Research & Development Expense	3.60	4.43	4.30	4.58	4.39	5.70	7.48	8.57	9.44	6.98	6.70
Total Other Income / (Expense), net	-0.03	-0.03	-0.04	-0.29	0.02	0.00	3.29	-0.22	0.20	0.06	0.33
Interest Expense	0.04	0.03	0.03	0.03	0.03	0.13	-2.02	0.21	0.31	0.32	0.34
Interest & Investment Income	0.01	0.01	0.00	0.00	0.02	0.08	0.06	-	0.06	0.47	0.54
Other Income / (Expense), net	0.00	-0.00	-0.01	-0.27	0.04	0.06	1.22	-0.02	0.45	-0.09	0.13
Income Tax Expense	1.35	1.55	3.56	1.04	-0.15	-2.54	-2.04	-1.97	1.16	6.30	0.16
Basic Earnings per Share	$0.40	$0.48	$0.43	$0.73	$0.07	($0.72)	($0.43)	($0.60)	$0.48	($0.99)	($0.12)
Weighted Average Basic Shares Outstanding	7.82M	7.61M	7.42M	7.44M	7.47M	7.83M	9.30M	9.91M	9.95M	10.00M	10.09M
Diluted Earnings per Share	$0.39	$0.47	$0.42	$0.70	$0.07	($0.72)	($0.43)	($0.60)	$0.47	($0.99)	($0.12)
Weighted Average Diluted Shares Outstanding	7.85M	7.66M	7.59M	7.76M	7.68M	7.83M	9.30M	9.91M	10.02M	10.00M	10.09M
Weighted Average Basic & Diluted Shares Outstanding	7.70M	7.50M	7.50M	7.40M	7.53M	8.96M	9.89M	9.94M	9.96M	10.08M	10.24M

This table shows TransAct Technologies' income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Period end date	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025	9/30/2025	12/31/2025	3/31/2026
Net Income / (Loss) Attributable to Common Shareholders	0.91	-0.06	-1.04	-0.32	-0.55	-7.96	0.02	-0.14	0.02	-1.13	0.77
Consolidated Net Income / (Loss)	0.91	-0.06	-1.04	-0.32	-0.55	-7.96	0.02	-0.14	0.02	-1.13	0.77
Net Income / (Loss) Continuing Operations	0.91	-0.06	-1.04	-0.32	-0.55	-7.96	0.02	-0.14	0.02	-1.13	0.77
Total Pre-Tax Income	1.08	-0.10	-1.31	-0.41	-0.70	-1.15	0.07	-0.10	0.04	-1.09	0.79
Total Operating Income	1.19	-0.52	-1.30	-0.44	-0.84	-1.05	-0.02	-0.26	0.01	-1.16	0.77
Total Gross Profit	8.92	6.37	5.62	6.11	5.23	4.52	6.36	6.65	6.56	5.45	7.25
Total Revenue	17	13	11	12	11	10	13	14	13	11	14
Operating Revenue	17	13	11	12	11	10	13	14	13	11	14
Total Cost of Revenue	8.27	6.89	5.06	5.49	5.64	5.71	6.69	7.15	6.62	6.01	7.16
Operating Cost of Revenue	8.27	6.89	5.06	5.49	5.64	5.71	6.69	7.15	6.62	6.01	7.16
Total Operating Expenses	7.73	6.89	6.93	6.55	6.06	5.57	6.37	6.91	6.54	6.60	6.48
Selling, General & Admin Expense	2.82	2.64	2.88	2.55	2.54	1.96	2.65	3.08	2.80	2.77	2.91
Marketing Expense	2.40	2.10	2.08	2.20	1.88	2.04	2.09	2.10	2.09	2.15	2.20
Research & Development Expense	2.51	2.16	1.97	1.80	1.64	1.57	1.64	1.73	1.66	1.69	1.38
Total Other Income / (Expense), net	-0.12	0.43	-0.01	0.03	0.14	-0.10	0.09	0.16	0.03	0.07	0.02
Interest & Investment Income	-0.07	0.26	0.05	0.03	0.04	0.35	0.02	0.04	0.06	0.41	0.07
Other Income / (Expense), net	-0.04	0.47	-0.06	0.01	0.10	-0.13	0.06	0.12	-0.04	-0.01	-0.05
Income Tax Expense	0.17	-0.03	-0.28	-0.09	-0.15	6.81	0.05	0.04	0.03	0.04	0.02
Basic Earnings per Share	$0.09	($0.01)	($0.10)	($0.03)	($0.06)	($0.80)	$0.00	($0.01)	$0.00	($0.11)	$0.08
Weighted Average Basic Shares Outstanding	9.96M	9.95M	9.97M	10.00M	10.01M	10.00M	10.04M	10.09M	10.10M	10.09M	10.18M
Diluted Earnings per Share	$0.09	($0.01)	($0.10)	($0.03)	($0.06)	($0.80)	$0.00	($0.01)	$0.00	($0.11)	$0.07
Weighted Average Diluted Shares Outstanding	10.05M	10.02M	9.97M	10.00M	10.01M	10.00M	10.05M	10.09M	10.16M	10.09M	10.23M
Weighted Average Basic & Diluted Shares Outstanding	9.96M	9.96M	9.99M	10.00M	10.01M	10.08M	10.08M	10.09M	10.11M	10.24M	10.28M

This table details how cash moves in and out of TransAct Technologies' business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Net Change in Cash & Equivalents	1.34	-1.97	3.00	-0.88	-0.42	6.16	9.10	-12	4.38	2.07	6.04
Net Cash From Operating Activities	5.55	4.62	5.92	5.11	4.85	-3.51	-2.51	-12	5.51	1.86	7.67
Net Cash From Continuing Operating Activities	5.55	4.62	5.92	5.11	4.85	-3.51	-2.51	-12	5.51	1.86	7.67
Net Income / (Loss) Continuing Operations	3.09	3.62	3.21	5.43	0.52	-5.63	-4.04	-5.94	4.75	-9.86	-1.24
Consolidated Net Income / (Loss)	3.09	3.62	3.21	5.43	0.52	-5.63	-4.04	-5.94	4.75	-9.86	-1.24
Depreciation Expense	1.43	1.33	1.08	1.00	1.37	1.34	0.96	1.33	1.49	1.04	0.67
Non-Cash Adjustments To Reconcile Net Income	-3.14	0.61	0.67	0.93	0.73	0.82	-2.19	1.16	0.83	1.25	1.58
Changes in Operating Assets and Liabilities, net	4.17	-0.93	0.96	-2.25	2.23	-0.04	2.76	-8.78	-1.56	9.44	6.66
Net Cash From Investing Activities	-0.96	-0.60	-0.99	-1.47	-2.37	-1.34	0.22	-1.30	-0.90	-0.32	-1.61
Net Cash From Continuing Investing Activities	-0.96	-0.60	-0.99	-1.47	-2.37	-1.34	0.22	-1.30	-0.90	-0.32	-1.61
Purchase of Property, Plant & Equipment	-0.96	-0.61	-0.99	-1.47	-1.37	-0.74	-1.38	-1.30	-0.90	-0.32	-1.61
Net Cash From Financing Activities	-3.24	-5.96	-1.92	-4.52	-2.90	11	11	2.06	-0.09	0.63	-0.12
Net Cash From Continuing Financing Activities	-3.24	-5.96	-1.92	-4.52	-2.90	11	11	2.06	-0.09	0.63	-0.12
Repayment of Debt	-2.50	0.00	-	-	0.00	-2.97	-0.03	-0.07	0.00	-0.05	0.00
Issuance of Debt	2.50	-	-	-	0.00	4.93	0.00	2.25	0.00	0.75	0.00
Other Financing Activities, net	0.26	0.02	1.02	0.15	-0.21	0.33	0.30	-0.12	-0.09	-0.07	-0.12
Effect of Exchange Rate Changes	-0.01	-0.03	-0.01	-	-	-0.02	-0.09	-0.05	-0.14	-0.10	0.10
Cash Interest Paid	0.03	0.03	0.03	0.03	0.03	0.06	0.08	0.13	0.27	0.27	0.32
Cash Income Taxes Paid	0.13	2.07	2.99	1.25	0.07	0.05	0.06	0.06	0.16	0.50	0.16

This table details how cash moves in and out of TransAct Technologies' business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Period end date	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025	9/30/2025	12/31/2025	3/31/2026
Net Change in Cash & Equivalents	0.85	0.72	-1.69	0.50	0.21	3.05	-0.22	3.57	2.30	0.39	-1.59
Net Cash From Operating Activities	0.90	0.92	-1.49	0.64	0.33	2.39	-0.16	3.60	3.63	0.61	-0.95
Net Cash From Continuing Operating Activities	0.90	0.92	-1.49	0.64	0.33	2.39	-0.16	3.60	3.63	0.61	-0.95
Net Income / (Loss) Continuing Operations	0.91	-0.06	-1.04	-0.32	-0.55	-7.96	0.02	-0.14	0.02	-1.13	0.77
Consolidated Net Income / (Loss)	0.91	-0.06	-1.04	-0.32	-0.55	-7.96	0.02	-0.14	0.02	-1.13	0.77
Depreciation Expense	0.38	0.39	0.40	0.24	0.21	0.19	0.17	0.17	0.16	0.17	0.16
Non-Cash Adjustments To Reconcile Net Income	0.21	0.20	0.33	0.27	0.23	0.42	0.26	0.35	0.45	0.52	0.56
Changes in Operating Assets and Liabilities, net	-0.60	0.40	-1.18	0.44	0.44	9.74	-0.61	3.22	3.00	1.05	-2.43
Net Cash From Investing Activities	-0.10	-0.11	-0.11	-0.14	-0.07	-0.01	-0.01	-0.02	-1.41	-0.17	-0.56
Net Cash From Continuing Investing Activities	-0.10	-0.11	-0.11	-0.14	-0.07	-0.01	-0.01	-0.02	-1.41	-0.17	-0.56
Purchase of Property, Plant & Equipment	-0.10	-0.11	-0.11	-0.14	-0.07	-0.01	-0.01	-0.02	-1.41	-0.17	-0.56
Net Cash From Financing Activities	-	-0.00	-0.07	-	-	0.71	-0.05	-	-0.03	-0.04	-0.07
Net Cash From Continuing Financing Activities	-	-0.00	-0.07	-	-	0.71	-0.05	-	-0.03	-0.04	-0.07
Other Financing Activities, net	-	-0.00	-0.07	-	-	-	-0.05	-	-0.03	-0.04	-0.07
Effect of Exchange Rate Changes	0.05	-0.09	-0.02	0.00	-0.05	-0.03	0.01	-0.01	-	-	-0.02

This table presents TransAct Technologies' assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Total Assets	33	32	34	35	36	42	51	52	54	44	45
Total Current Assets	23	23	26	27	25	28	37	36	41	38	39
Cash & Equivalents	4.47	2.50	5.51	4.69	4.20	10	19	7.95	12	14	20
Accounts Receivable	7.17	11	11	8.03	6.42	3.38	7.59	14	9.82	6.51	6.36
Inventories, net	11	9.71	8.88	13	12	11	7.71	12	18	16	11
Current Deferred & Refundable Income Taxes	-	0.00	0.51	0.81	0.18	2.41	-	0.00	0.32	0.40	0.40
Other Current Assets	0.44	0.37	0.52	0.68	1.00	0.64	0.74	0.72	0.77	0.90	0.75
Plant, Property, & Equipment, net	2.51	2.24	2.17	2.27	2.24	1.95	2.68	2.78	2.42	1.82	1.24
Total Noncurrent Assets	6.68	6.63	5.42	5.65	8.90	12	11	13	11	3.85	4.72
Goodwill	2.62	2.62	2.62	2.62	2.62	2.62	2.62	2.62	2.62	2.62	2.62
Intangible Assets	0.89	0.55	0.46	0.80	0.82	0.58	0.40	0.24	0.09	0.00	1.50
Other Noncurrent Operating Assets	0.03	0.04	0.03	0.03	2.90	4.40	2.95	2.74	1.77	1.23	0.59
Total Liabilities & Shareholders' Equity	33	32	34	35	36	42	51	52	54	44	45
Total Liabilities	6.84	7.93	7.94	7.39	10	12	12	18	15	13	14
Total Current Liabilities	6.33	7.42	7.35	6.63	7.65	6.70	9.80	16	14	13	13
Short-Term Debt	-	-	-	-	-	-	0.00	2.25	2.25	3.00	3.00
Accounts Payable	2.64	4.89	3.84	3.48	2.96	1.69	4.31	7.40	4.43	4.57	3.54
Accrued Expenses	2.84	2.39	3.34	2.77	3.04	3.67	3.89	4.08	4.95	3.25	4.76
Current Deferred Revenue	0.60	0.12	0.17	0.38	0.70	0.50	0.81	1.33	1.08	1.11	1.40
Other Current Liabilities	-	-	-	0.00	0.95	0.84	0.79	0.88	0.93	0.96	0.35
Total Noncurrent Liabilities	0.51	0.51	0.59	0.76	2.49	5.31	2.15	2.04	1.15	0.52	0.61
Noncurrent Deferred Revenue	0.27	0.25	0.34	0.52	0.22	0.11	0.19	0.14	0.21	0.25	0.36
Other Noncurrent Operating Liabilities	0.25	0.26	0.25	0.24	2.27	3.03	1.97	1.90	0.94	0.27	0.25
Commitments & Contingencies	-	-	-	-	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	26	24	26	28	26	30	39	34	39	31	31
Total Preferred & Common Equity	26	24	26	28	26	30	39	34	39	31	31
Total Common Equity	26	24	26	28	26	30	39	34	39	31	31
Common Stock	29	30	31	32	33	43	55	56	57	58	60
Retained Earnings	23	24	25	28	25	20	16	9.63	14	4.52	3.28
Treasury Stock	-26	-30	-30	-32	-32	-32	-32	-32	-32	-32	-32
Accumulated Other Comprehensive Income / (Loss)	-0.08	-0.11	-0.10	-0.08	-0.03	-0.04	0.14	-0.08	-0.05	-0.05	-0.01

This table presents TransAct Technologies' assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q3 2023	Q1 2024	Q2 2024	Q3 2024	Q1 2025	Q2 2025	Q3 2025	Q1 2026
Period end date	9/30/2023	3/31/2024	6/30/2024	9/30/2024	3/31/2025	6/30/2025	9/30/2025	3/31/2026
Total Assets	57	52	50	51	44	45	45	48
Total Current Assets	43	39	37	37	39	40	39	39
Cash & Equivalents	12	11	11	11	14	18	20	19
Accounts Receivable	12	7.78	6.74	7.42	9.06	7.81	5.84	9.02
Inventories, net	18	19	18	17	14	13	12	9.57
Current Deferred & Refundable Income Taxes	-	0.35	0.71	0.71	0.40	0.43	0.43	0.38
Other Current Assets	1.31	0.93	0.80	1.08	0.86	0.74	1.11	0.89
Plant, Property, & Equipment, net	2.65	2.19	2.13	1.99	1.65	1.51	1.39	1.17
Total Noncurrent Assets	11	11	11	11	3.60	3.35	4.44	8.01
Goodwill	2.62	2.62	2.62	2.62	2.62	2.62	2.62	2.62
Intangible Assets	0.13	0.05	0.01	0.00	0.00	0.00	1.35	1.98
Other Noncurrent Operating Assets	2.02	1.50	1.70	1.46	0.98	0.73	0.47	3.40
Total Liabilities & Shareholders' Equity	57	52	50	51	44	45	45	48
Total Liabilities	17	13	12	12	13	13	13	16
Total Current Liabilities	16	12	11	11	13	13	13	12
Short-Term Debt	2.25	2.25	2.25	2.25	3.00	3.00	3.00	3.00
Accounts Payable	6.24	4.23	3.04	3.21	4.67	3.93	3.70	4.41
Accrued Expenses	5.72	4.13	3.65	3.88	3.11	4.10	4.54	3.11
Current Deferred Revenue	0.98	0.93	0.84	0.93	1.13	1.16	1.14	1.34
Other Current Liabilities	0.92	0.94	0.94	0.98	0.85	0.70	0.44	0.50
Total Noncurrent Liabilities	1.39	0.88	1.11	0.90	0.47	0.38	0.38	3.23
Noncurrent Deferred Revenue	0.20	0.20	0.20	0.24	0.34	0.33	0.34	0.32
Other Noncurrent Operating Liabilities	1.19	0.68	0.92	0.66	0.14	0.05	0.04	2.91
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	39	39	39	38	31	31	32	32
Total Preferred & Common Equity	39	39	39	38	31	31	32	32
Total Common Equity	39	39	39	38	31	31	32	32
Common Stock	57	57	58	58	59	59	59	60
Retained Earnings	14	13	13	12	4.53	4.39	4.41	4.04
Treasury Stock	-32	-32	-32	-32	-32	-32	-32	-32
Accumulated Other Comprehensive Income / (Loss)	-0.10	-0.05	-0.05	-0.01	-0.04	-0.00	-0.02	-0.05

This table displays calculated financial ratios and metrics derived from TransAct Technologies' official financial filings.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
DEI Shares Outstanding	0.00	7,346,459.00	7,346,459.00	7,391,028.00	0.00	8,928,885.00	9,835,379.00	9,911,533.00	9,958,118.00	10,010,357.00	10,112,585.00
DEI Adjusted Shares Outstanding	0.00	7,346,459.00	7,346,459.00	7,391,028.00	0.00	8,928,885.00	9,835,379.00	9,911,533.00	9,958,118.00	10,010,357.00	10,112,585.00
DEI Earnings Per Adjusted Shares Outstanding	0.00	0.49	0.44	0.73	0.00	-0.63	-0.41	-0.60	0.48	-0.99	-0.12
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	12.37%	-4.09%	-1.61%	-3.06%	-16.19%	-33.12%	28.73%	47.61%	24.93%	-40.27%	18.66%
EBITDA Growth	349.83%	10.70%	20.82%	-5.02%	-76.65%	-487.36%	-6.32%	11.69%	220.22%	-135.02%	77.22%
EBIT Growth	217.48%	16.24%	30.97%	-4.58%	-94.18%	-2,247.35%	-0.53%	5.72%	180.05%	-160.33%	65.49%
NOPAT Growth	217.79%	16.97%	-11.19%	75.55%	-91.50%	-1,286.32%	-14.73%	18.13%	185.40%	-155.30%	60.98%
Net Income Growth	227.72%	16.98%	-11.22%	68.98%	-90.49%	-1,191.09%	28.22%	-46.89%	179.99%	-307.73%	87.43%
EPS Growth	234.48%	20.51%	-10.64%	66.67%	-90.00%	-1,128.57%	40.28%	-39.53%	178.33%	-310.64%	87.88%
Operating Cash Flow Growth	-8.29%	-16.70%	27.98%	-13.67%	-5.15%	-172.43%	28.49%	-386.85%	145.07%	-66.21%	312.31%
Free Cash Flow Firm Growth	-12.04%	-20.18%	31.73%	-23.72%	-50.49%	-469.86%	35.45%	-262.46%	124.12%	121.71%	-39.66%
Invested Capital Growth	-4.53%	1.65%	-5.09%	11.55%	-5.04%	1.51%	-12.06%	45.26%	4.18%	-34.43%	-28.88%
Revenue Q/Q Growth	-0.30%	1.86%	0.06%	-2.57%	-1.28%	-10.00%	9.33%	13.32%	-6.07%	-6.54%	2.43%
EBITDA Q/Q Growth	887.60%	24.11%	-4.67%	-6.41%	-45.75%	-33.18%	13.62%	32.32%	-6.44%	-98.22%	-2.01%
EBIT Q/Q Growth	631.51%	31.61%	-3.30%	-7.89%	-82.97%	-25.48%	15.39%	27.55%	-8.39%	-43.94%	1.23%
NOPAT Q/Q Growth	643.15%	24.67%	-34.05%	36.72%	-81.15%	-24.46%	2.23%	27.70%	-11.38%	-17.04%	-8.10%
Net Income Q/Q Growth	744.17%	23.83%	-33.81%	33.91%	-77.35%	-24.78%	23.07%	14.00%	-6.35%	-401.17%	84.63%
EPS Q/Q Growth	1,075.00%	23.68%	-34.38%	37.25%	-75.86%	-22.03%	30.65%	10.45%	-7.84%	-395.00%	85.19%
Operating Cash Flow Q/Q Growth	5.69%	-24.58%	18.24%	-11.90%	96.99%	-1,400.00%	21.98%	4.42%	-16.37%	378.41%	-18.82%
Free Cash Flow Firm Q/Q Growth	0.58%	-30.33%	18.15%	-7.52%	570.72%	-107.49%	-32.71%	10.39%	-21.36%	569.75%	-66.45%
Invested Capital Q/Q Growth	-8.22%	1.16%	-9.23%	-1.27%	-16.69%	-9.61%	-5.97%	-2.81%	-1.60%	-34.25%	-7.15%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	41.86%	41.58%	47.35%	48.99%	47.95%	42.26%	39.05%	41.99%	52.87%	49.52%	48.59%
EBITDA Margin	9.88%	11.40%	14.00%	13.72%	3.82%	-22.14%	-18.29%	-10.94%	10.53%	-6.17%	-1.18%
Operating Margin	7.49%	9.09%	12.10%	12.38%	0.75%	-26.71%	-23.81%	-13.20%	7.86%	-8.36%	-2.75%
EBIT Margin	7.49%	9.08%	12.08%	11.89%	0.83%	-26.53%	-20.72%	-13.23%	8.48%	-8.56%	-2.49%
Profit (Net Income) Margin	5.18%	6.32%	5.70%	9.94%	1.13%	-18.40%	-10.26%	-10.21%	6.54%	-22.73%	-2.41%
Tax Burden Percent	69.61%	69.96%	47.42%	83.92%	140.60%	68.92%	66.43%	75.13%	80.43%	276.43%	114.39%
Interest Burden Percent	99.37%	99.50%	99.52%	99.58%	97.09%	100.64%	74.55%	102.70%	95.86%	96.04%	84.56%
Effective Tax Rate	30.39%	30.04%	52.58%	16.08%	-40.60%	0.00%	0.00%	0.00%	19.57%	0.00%	0.00%
Return on Invested Capital (ROIC)	14.29%	16.98%	15.34%	26.15%	2.16%	-26.14%	-31.68%	-22.60%	15.96%	-10.45%	-6.02%
ROIC Less NNEP Spread (ROIC-NNEP)	14.77%	17.58%	15.84%	30.97%	1.40%	-27.61%	-49.84%	-18.16%	13.95%	57.80%	-4.29%
Return on Net Nonoperating Assets (RNNOA)	-2.20%	-2.46%	-2.53%	-5.89%	-0.23%	6.09%	20.00%	6.30%	-3.00%	-17.71%	2.00%
Return on Equity (ROE)	12.10%	14.52%	12.81%	20.25%	1.93%	-20.05%	-11.68%	-16.30%	12.96%	-28.16%	-4.02%
Cash Return on Invested Capital (CROIC)	18.93%	15.34%	20.56%	15.23%	7.33%	-27.63%	-18.84%	-59.51%	11.87%	31.15%	27.74%
Operating Return on Assets (OROA)	13.14%	16.08%	20.62%	18.85%	1.06%	-20.73%	-17.51%	-14.97%	11.62%	-7.56%	-2.89%
Return on Assets (ROA)	9.09%	11.20%	9.73%	15.75%	1.45%	-14.38%	-8.67%	-11.55%	8.96%	-20.08%	-2.79%
Return on Common Equity (ROCE)	12.10%	14.52%	12.81%	20.25%	1.93%	-20.05%	-11.68%	-16.30%	12.96%	-28.16%	-4.02%
Return on Equity Simple (ROE_SIMPLE)	12.02%	15.00%	12.34%	19.68%	1.99%	-18.62%	-10.37%	-17.53%	12.05%	0.00%	0.00%
Net Operating Profit after Tax (NOPAT)	3.11	3.64	3.23	5.67	0.48	-5.72	-6.56	-5.37	4.59	-2.54	-0.99
NOPAT Margin	5.21%	6.36%	5.74%	10.39%	1.05%	-18.70%	-16.67%	-9.24%	6.32%	-5.85%	-1.92%
Net Nonoperating Expense Percent (NNEP)	-0.48%	-0.60%	-0.50%	-4.82%	0.76%	1.47%	18.16%	-4.45%	2.01%	-68.25%	-1.73%
Return On Investment Capital (ROIC_SIMPLE)	-	-	-	-	-	-	-	-	11.02%	-7.55%	-2.90%
Cost of Revenue to Revenue	58.14%	58.42%	52.65%	51.01%	52.05%	57.74%	60.95%	58.01%	47.13%	50.48%	51.41%
SG&A Expenses to Revenue	12.35%	12.70%	14.18%	15.03%	20.04%	30.25%	24.44%	20.97%	18.34%	22.90%	21.94%
R&D to Revenue	6.03%	7.73%	7.64%	8.38%	9.60%	18.64%	18.98%	14.74%	13.00%	16.08%	13.02%
Operating Expenses to Revenue	34.37%	32.50%	35.25%	36.61%	47.20%	68.97%	62.86%	55.19%	45.01%	57.87%	51.34%
Earnings before Interest and Taxes (EBIT)	4.47	5.20	6.81	6.49	0.38	-8.12	-8.16	-7.69	6.16	-3.72	-1.28
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	5.90	6.53	7.89	7.49	1.75	-6.78	-7.20	-6.36	7.65	-2.68	-0.61
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	0.00	0.00	0.00	2.33	3.16	2.10	2.75	1.85	1.76	1.34	1.30
Price to Tangible Book Value (P/TBV)	0.00	0.00	0.00	2.66	3.64	2.35	2.98	2.02	1.89	1.46	1.50
Price to Revenue (P/Rev)	0.00	0.00	0.00	1.17	1.79	2.07	2.72	1.08	0.96	0.94	0.79
Price to Earnings (P/E)	0.00	0.00	0.00	11.82	158.80	0.00	0.00	0.00	14.64	0.00	0.00
Dividend Yield	4.31%	5.36%	2.81%	4.15%	3.28%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	0.00%	0.00%	0.00%	8.46%	0.63%	0.00%	0.00%	0.00%	6.83%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	0.00	0.00	0.00	2.60	3.58	2.50	4.53	2.02	2.03	1.54	1.68
Enterprise Value to Revenue (EV/Rev)	0.00	0.00	0.00	1.09	1.70	1.80	2.23	0.98	0.82	0.68	0.45
Enterprise Value to EBITDA (EV/EBITDA)	0.00	0.00	0.00	7.94	44.45	0.00	0.00	0.00	7.77	0.00	0.00
Enterprise Value to EBIT (EV/EBIT)	0.00	0.00	0.00	9.15	205.66	0.00	0.00	0.00	9.65	0.00	0.00
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.00	0.00	10.48	161.20	0.00	0.00	0.00	12.95	0.00	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	0.00	0.00	0.00	11.64	16.04	0.00	0.00	0.00	10.79	15.88	3.00
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	0.00	18.00	47.54	0.00	0.00	0.00	17.42	3.91	5.04
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.00	0.00	0.00	0.00	0.00	0.07	0.00	0.07	0.06	0.10	0.10
Long-Term Debt to Equity	0.00	0.00	0.00	0.00	0.00	0.07	0.00	0.00	0.00	0.00	0.00
Financial Leverage	-0.15	-0.14	-0.16	-0.19	-0.17	-0.22	-0.40	-0.35	-0.22	-0.31	-0.47
Leverage Ratio	1.33	1.30	1.32	1.29	1.33	1.39	1.35	1.41	1.45	1.40	1.44
Compound Leverage Factor	1.32	1.29	1.31	1.28	1.29	1.40	1.00	1.45	1.39	1.35	1.22
Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	6.70%	0.00%	6.23%	5.40%	8.92%	8.79%
Short-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	6.23%	5.40%	8.92%	8.79%
Long-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	6.70%	0.00%	0.00%	0.00%	0.00%	0.00%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	100.00%	100.00%	100.00%	100.00%	100.00%	93.30%	100.00%	93.77%	94.60%	91.08%	91.21%
Debt to EBITDA	0.00	0.00	0.00	0.00	0.00	-0.32	0.00	-0.35	0.29	-1.12	-4.92
Net Debt to EBITDA	0.00	0.00	0.00	0.00	0.00	1.21	0.00	0.90	-1.32	4.25	28.58
Long-Term Debt to EBITDA	0.00	0.00	0.00	0.00	0.00	-0.32	0.00	0.00	0.00	0.00	0.00
Debt to NOPAT	0.00	0.00	0.00	0.00	0.00	-0.38	0.00	-0.42	0.49	-1.18	-3.03
Net Debt to NOPAT	0.00	0.00	0.00	0.00	0.00	1.43	0.00	1.06	-2.19	4.49	17.60
Long-Term Debt to NOPAT	0.00	0.00	0.00	0.00	0.00	-0.38	0.00	0.00	0.00	0.00	0.00
Altman Z-Score	0.00	0.00	0.00	9.18	7.71	4.52	6.70	3.45	5.51	3.38	3.63
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	3.69	3.12	3.59	4.08	3.26	4.21	3.79	2.27	3.01	2.98	2.97
Quick Ratio	1.84	1.76	2.24	1.92	1.52	2.07	2.91	1.47	1.62	1.62	2.05
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	4.12	3.29	4.33	3.30	1.64	-6.05	-3.90	-14	3.41	7.57	4.57
Operating Cash Flow to CapEx	581.26%	770.67%	600.81%	346.84%	354.76%	-471.77%	-182.41%	-940.72%	611.21%	577.95%	475.99%
Free Cash Flow to Firm to Interest Expense	111.30	99.61	131.21	122.33	58.40	-46.52	0.00	-68.03	11.01	23.50	13.47
Operating Cash Flow to Interest Expense	150.03	140.12	179.33	189.22	173.07	-27.00	0.00	-58.75	17.76	5.78	22.63
Operating Cash Flow Less CapEx to Interest Expense	124.22	121.94	149.48	134.67	124.29	-32.72	0.00	-65.00	14.86	4.78	17.88
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	1.75	1.77	1.71	1.58	1.29	0.78	0.85	1.13	1.37	0.88	1.16
Accounts Receivable Turnover	7.34	6.45	5.23	5.75	6.34	6.25	7.18	5.40	6.12	5.31	8.00
Inventory Turnover	3.00	3.18	3.19	2.57	1.91	1.51	2.53	3.42	2.30	1.29	1.96
Fixed Asset Turnover	24.14	24.11	25.54	24.58	20.26	14.59	17.00	21.28	27.92	20.47	33.64
Accounts Payable Turnover	13.86	8.87	6.79	7.60	7.39	7.60	8.00	5.76	5.79	4.87	6.53
Days Sales Outstanding (DSO)	49.75	56.63	69.79	63.43	57.62	58.43	50.83	67.55	59.68	68.70	45.63
Days Inventory Outstanding (DIO)	121.51	114.64	114.38	142.30	191.09	241.58	144.43	106.81	158.81	282.64	186.32
Days Payable Outstanding (DPO)	26.34	41.13	53.77	48.00	49.38	48.05	45.61	63.33	63.05	74.99	55.91
Cash Conversion Cycle (CCC)	144.92	130.13	130.40	157.72	199.33	251.96	149.65	111.04	155.44	276.35	176.04
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	21	22	21	23	22	22	19	28	29	19	14
Invested Capital Turnover	2.74	2.67	2.67	2.52	2.05	1.40	1.90	2.45	2.53	1.79	3.13
Increase / (Decrease) in Invested Capital	-1.01	0.35	-1.10	2.37	-1.15	0.33	-2.66	8.78	1.18	-10	-5.56
Enterprise Value (EV)	0.00	0.00	0.00	59	78	55	88	57	59	30	23
Market Capitalization	0.00	0.00	0.00	64	82	63	107	63	70	41	40
Book Value per Share	$3.29	$3.17	$3.50	$3.73	$3.47	$3.39	$3.96	$3.42	$3.96	$3.06	$3.08
Tangible Book Value per Share	$2.84	$2.75	$3.09	$3.27	$3.01	$3.03	$3.66	$3.13	$3.69	$2.80	$2.67
Total Capital	26	24	26	28	26	32	39	36	42	34	34
Total Debt	0.00	0.00	0.00	0.00	0.00	2.17	0.00	2.25	2.25	3.00	3.00
Total Long-Term Debt	0.00	0.00	0.00	0.00	0.00	2.17	0.00	0.00	0.00	0.00	0.00
Net Debt	-4.47	-2.50	-5.51	-4.69	-4.20	-8.19	-19	-5.70	-10	-11	-17
Capital Expenditures (CapEx)	0.96	0.60	0.99	1.47	1.37	0.74	1.38	1.30	0.90	0.32	1.61
Debt-free, Cash-free Net Working Capital (DFCFNWC)	13	13	14	16	13	11	7.88	15	17	14	8.33
Debt-free Net Working Capital (DFNWC)	17	16	19	20	17	21	27	22	30	28	29
Net Working Capital (NWC)	17	16	19	20	17	21	27	20	27	25	26
Net Nonoperating Expense (NNE)	0.02	0.02	0.02	0.25	-0.03	-0.09	-2.52	0.56	-0.16	7.32	0.25
Net Nonoperating Obligations (NNO)	-4.47	-2.50	-5.51	-4.69	-4.20	-8.19	-20	-5.70	-10	-11	-17
Total Depreciation and Amortization (D&A)	1.43	1.33	1.08	1.00	1.37	1.34	0.96	1.33	1.49	1.04	0.67
Debt-free, Cash-free Net Working Capital to Revenue	21.08%	23.13%	23.98%	28.79%	28.56%	36.34%	20.01%	24.95%	23.81%	32.46%	16.18%
Debt-free Net Working Capital to Revenue	28.57%	27.51%	33.76%	37.38%	37.75%	70.20%	69.42%	38.61%	40.77%	65.64%	55.87%
Net Working Capital to Revenue	28.57%	27.51%	33.76%	37.38%	37.75%	70.20%	69.42%	34.74%	37.67%	58.73%	50.04%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.40	$0.48	$0.43	$0.73	$0.07	($0.72)	($0.45)	($0.60)	$0.48	($0.99)	($0.12)
Adjusted Weighted Average Basic Shares Outstanding	7.82M	7.61M	7.42M	7.44M	7.47M	7.83M	9.30M	9.91M	9.95M	10.00M	10.09M
Adjusted Diluted Earnings per Share	$0.39	$0.47	$0.42	$0.70	$0.07	($0.72)	($0.45)	($0.60)	$0.47	($0.99)	($0.12)
Adjusted Weighted Average Diluted Shares Outstanding	7.85M	7.66M	7.59M	7.76M	7.68M	7.83M	9.30M	9.91M	10.02M	10.00M	10.09M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	7.78M	7.35M	7.48M	7.45M	7.53M	8.96M	9.89M	9.94M	9.96M	10.08M	10.24M
Normalized Net Operating Profit after Tax (NOPAT)	4.32	3.64	4.77	5.67	0.24	-5.72	-6.56	-5.37	4.59	-2.54	-0.99
Normalized NOPAT Margin	7.24%	6.36%	8.47%	10.39%	0.52%	-18.70%	-16.67%	-9.24%	6.32%	-5.85%	-1.92%
Pre Tax Income Margin	7.44%	9.03%	12.03%	11.85%	0.80%	-26.70%	-15.44%	-13.59%	8.13%	-8.22%	-2.11%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	120.81	157.45	206.21	240.48	13.50	-62.44	0.00	-36.99	19.86	-11.54	-3.78
NOPAT to Interest Expense	84.06	110.24	97.91	210.07	17.22	-44.01	0.00	-25.84	14.81	-7.88	-2.92
EBIT Less CapEx to Interest Expense	95.00	139.27	176.36	185.93	-35.29	-68.16	0.00	-43.23	16.96	-12.54	-8.54
NOPAT Less CapEx to Interest Expense	58.25	92.06	68.06	155.51	-31.56	-49.73	0.00	-32.08	11.90	-8.88	-7.68
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	80.37%	66.80%	80.38%	49.15%	519.96%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	113.36%	165.52%	91.53%	86.01%	519.96%	-18.85%	-25.09%	0.00%	0.00%	0.00%	0.00%

This table displays calculated financial ratios and metrics derived from TransAct Technologies' official financial filings.

Metric	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Period end date	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025	9/30/2025	12/31/2025	3/31/2026
DEI Shares Outstanding	9,958,118.00	9,958,118.00	9,964,674.00	9,994,907.00	9,998,307.00	10,010,357.00	10,080,717.00	10,080,717.00	10,092,326.00	10,112,585.00	10,239,045.00
DEI Adjusted Shares Outstanding	9,958,118.00	9,958,118.00	9,964,674.00	9,994,907.00	9,998,307.00	10,010,357.00	10,080,717.00	10,080,717.00	10,092,326.00	10,112,585.00	10,239,045.00
DEI Earnings Per Adjusted Shares Outstanding	0.09	-0.01	-0.10	-0.03	-0.06	-0.79	0.00	-0.01	0.00	-0.11	0.07
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	-3.73%	-26.13%	-52.01%	-41.73%	-36.78%	-22.87%	22.14%	18.96%	21.25%	11.94%	10.43%
EBITDA Growth	74.15%	-59.86%	-123.08%	-111.92%	-134.86%	-392.60%	122.88%	114.74%	126.64%	-1.21%	298.64%
EBIT Growth	121.19%	-109.72%	-135.50%	-135.21%	-164.55%	-2,362.50%	103.53%	66.82%	97.17%	1.35%	1,406.25%
NOPAT Growth	128.91%	-265.57%	-128.67%	-137.85%	-158.37%	-101.15%	99.55%	41.10%	100.90%	-10.10%	18,484.95%
Net Income Growth	71.59%	-123.85%	-133.00%	-141.70%	-160.82%	-12,733.87%	101.83%	55.17%	102.72%	85.79%	3,931.58%
EPS Growth	80.00%	-133.33%	-132.26%	-137.50%	-166.67%	-7,900.00%	100.00%	66.67%	100.00%	86.25%	0.00%
Operating Cash Flow Growth	140.91%	-54.06%	-96.83%	-85.70%	-63.71%	160.70%	89.19%	465.25%	1,010.09%	-74.50%	-487.58%
Free Cash Flow Firm Growth	102.08%	81.97%	134.79%	-7,432.00%	-116.93%	707.43%	512.65%	3,625.48%	52,176.16%	-49.34%	-61.00%
Invested Capital Growth	2.90%	4.18%	-7.96%	0.20%	-1.87%	-34.43%	-34.54%	-44.21%	-49.64%	-28.88%	-16.78%
Revenue Q/Q Growth	-13.64%	-22.83%	-19.43%	8.53%	-6.31%	-5.85%	27.58%	5.71%	-4.51%	-13.08%	25.86%
EBITDA Q/Q Growth	-4.08%	-77.89%	-385.80%	80.33%	-180.53%	-85.55%	122.35%	-87.33%	407.14%	-804.93%	188.01%
EBIT Q/Q Growth	-6.21%	-104.18%	-2,735.42%	68.33%	-71.93%	-59.51%	104.06%	-397.92%	85.31%	-5,452.38%	162.01%
NOPAT Q/Q Growth	23.92%	-136.40%	-149.23%	66.33%	-91.10%	-25.45%	99.45%	-4,335.82%	102.91%	-15,513.33%	192.50%
Net Income Q/Q Growth	18.43%	-106.84%	-1,570.97%	69.21%	-72.73%	-1,344.10%	100.24%	-852.63%	110.49%	-7,640.00%	167.73%
EPS Q/Q Growth	12.50%	-111.11%	-900.00%	70.00%	-100.00%	-1,233.33%	100.00%	0.00%	100.00%	0.00%	163.64%
Operating Cash Flow Q/Q Growth	-79.74%	1.66%	-262.66%	142.68%	-48.58%	630.28%	-106.74%	2,332.92%	0.97%	-83.22%	-255.34%
Free Cash Flow Firm Q/Q Growth	3,195.27%	-1,036.13%	210.30%	-121.55%	92.39%	33,680.65%	11.25%	24.00%	12.42%	-67.33%	-14.37%
Invested Capital Q/Q Growth	0.79%	-1.60%	2.89%	-1.81%	-1.29%	-34.25%	2.72%	-16.31%	-10.90%	-7.15%	20.20%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	51.87%	48.03%	52.62%	52.68%	48.10%	44.19%	48.72%	48.21%	49.76%	47.57%	50.32%
EBITDA Margin	8.89%	2.55%	-9.04%	-1.64%	-4.90%	-9.67%	1.69%	0.20%	1.08%	-8.74%	6.11%
Operating Margin	6.93%	-3.94%	-12.17%	-3.78%	-7.70%	-10.26%	-0.11%	-1.87%	0.11%	-10.09%	5.35%
EBIT Margin	6.68%	-0.36%	-12.74%	-3.72%	-6.82%	-11.55%	0.37%	-1.04%	-0.16%	-10.18%	5.02%
Profit (Net Income) Margin	5.27%	-0.47%	-9.69%	-2.75%	-5.07%	-77.77%	0.15%	-1.04%	0.11%	-9.88%	5.31%
Tax Burden Percent	84.28%	64.58%	78.90%	78.77%	78.83%	691.31%	27.14%	138.84%	37.50%	103.67%	97.08%
Interest Burden Percent	93.64%	200.00%	96.47%	93.97%	94.33%	97.38%	145.83%	72.03%	-190.48%	93.57%	109.13%
Effective Tax Rate	15.72%	0.00%	0.00%	0.00%	0.00%	0.00%	72.86%	0.00%	62.50%	0.00%	2.92%
Return on Invested Capital (ROIC)	15.36%	-6.96%	-16.52%	-4.71%	-8.47%	-12.83%	-0.06%	-2.72%	0.09%	-22.10%	15.16%
ROIC Less NNEP Spread (ROIC-NNEP)	16.79%	-10.81%	-14.56%	-4.57%	-8.85%	54.46%	-0.29%	-3.04%	0.02%	-19.86%	15.03%
Return on Net Nonoperating Assets (RNNOA)	-3.16%	2.33%	2.45%	1.04%	2.11%	-16.69%	0.08%	1.03%	-0.01%	9.27%	-6.42%
Return on Equity (ROE)	12.19%	-4.63%	-14.06%	-3.67%	-6.37%	-29.52%	0.03%	-1.69%	0.08%	-12.82%	8.73%
Cash Return on Invested Capital (CROIC)	14.76%	11.87%	9.60%	-2.73%	-5.45%	31.15%	35.19%	50.20%	61.86%	27.74%	15.88%
Operating Return on Assets (OROA)	9.69%	-0.50%	-14.96%	-3.69%	-5.91%	-10.20%	0.35%	-1.05%	-0.17%	-11.80%	5.76%
Return on Assets (ROA)	7.65%	-0.64%	-11.39%	-2.73%	-4.39%	-68.70%	0.14%	-1.05%	0.12%	-11.45%	6.10%
Return on Common Equity (ROCE)	12.19%	-4.63%	-14.06%	-3.67%	-6.37%	-29.52%	0.03%	-1.69%	0.08%	-12.82%	8.73%
Return on Equity Simple (ROE_SIMPLE)	12.94%	0.00%	1.49%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Net Operating Profit after Tax (NOPAT)	1.00	-0.37	-0.91	-0.31	-0.59	-0.74	-0.00	-0.18	0.01	-0.81	0.75
NOPAT Margin	5.84%	-2.75%	-8.52%	-2.64%	-5.39%	-7.18%	-0.03%	-1.31%	0.04%	-7.07%	5.19%
Net Nonoperating Expense Percent (NNEP)	-1.43%	3.85%	-1.96%	-0.14%	0.38%	-67.29%	0.24%	0.32%	0.07%	-2.23%	0.13%
Return On Investment Capital (ROIC_SIMPLE)	-	-0.88%	-2.23%	-0.75%	-1.44%	-2.19%	-0.01%	-0.53%	0.02%	-2.37%	2.12%
Cost of Revenue to Revenue	48.13%	51.97%	47.38%	47.32%	51.90%	55.81%	51.28%	51.79%	50.24%	52.43%	49.68%
SG&A Expenses to Revenue	16.40%	19.89%	26.91%	22.00%	23.41%	19.20%	20.33%	22.34%	21.21%	24.14%	20.15%
R&D to Revenue	14.60%	16.28%	18.40%	15.51%	15.09%	15.37%	12.53%	12.50%	12.57%	14.71%	9.57%
Operating Expenses to Revenue	44.94%	51.96%	64.80%	56.45%	55.80%	54.45%	48.83%	50.08%	49.65%	57.66%	44.97%
Earnings before Interest and Taxes (EBIT)	1.15	-0.05	-1.36	-0.43	-0.74	-1.18	0.05	-0.14	-0.02	-1.17	0.72
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	1.53	0.34	-0.97	-0.19	-0.53	-0.99	0.22	0.03	0.14	-1.00	0.88
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	1.63	1.76	1.35	0.98	1.27	1.34	1.20	1.18	1.72	1.30	1.04
Price to Tangible Book Value (P/TBV)	1.76	1.89	1.45	1.05	1.36	1.46	1.31	1.29	1.97	1.50	1.22
Price to Revenue (P/Rev)	0.83	0.96	0.86	0.71	1.05	0.94	0.81	0.77	1.09	0.79	0.64
Price to Earnings (P/E)	12.61	14.64	91.13	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	7.93%	6.83%	1.10%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	1.83	2.03	1.45	0.97	1.35	1.54	1.31	1.34	2.56	1.68	1.09
Enterprise Value to Revenue (EV/Rev)	0.71	0.82	0.72	0.55	0.85	0.68	0.57	0.46	0.75	0.45	0.34
Enterprise Value to EBITDA (EV/EBITDA)	6.68	7.77	17.57	40.50	0.00	0.00	0.00	0.00	0.00	0.00	356.91
Enterprise Value to EBIT (EV/EBIT)	8.12	9.65	45.52	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to NOPAT (EV/NOPAT)	10.54	12.95	106.22	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	8.29	10.79	9.18	29.90	101.54	15.88	8.13	3.60	3.98	3.00	2.59
Enterprise Value to Free Cash Flow (EV/FCFF)	12.58	17.42	14.49	0.00	0.00	3.91	2.95	1.91	2.77	5.04	6.21
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.06	0.06	0.06	0.06	0.06	0.10	0.10	0.10	0.09	0.10	0.09
Long-Term Debt to Equity	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Financial Leverage	-0.19	-0.22	-0.17	-0.23	-0.24	-0.31	-0.28	-0.34	-0.37	-0.47	-0.43
Leverage Ratio	1.47	1.45	1.37	1.39	1.38	1.40	1.38	1.36	1.36	1.44	1.46
Compound Leverage Factor	1.38	2.89	1.32	1.30	1.30	1.37	2.02	0.98	-2.59	1.35	1.59
Debt to Total Capital	5.43%	5.40%	5.51%	5.52%	5.54%	8.92%	8.84%	8.75%	8.63%	8.79%	8.50%
Short-Term Debt to Total Capital	5.43%	5.40%	5.51%	5.52%	5.54%	8.92%	8.84%	8.75%	8.63%	8.79%	8.50%
Long-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	94.57%	94.60%	94.49%	94.48%	94.46%	91.08%	91.16%	91.25%	91.37%	91.21%	91.50%
Debt to EBITDA	0.28	0.29	0.90	3.16	-1.67	-1.12	-2.01	-2.36	-5.02	-4.92	60.00
Net Debt to EBITDA	-1.14	-1.32	-3.36	-12.50	6.73	4.25	7.50	11.58	28.50	28.58	-316.82
Long-Term Debt to EBITDA	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Debt to NOPAT	0.43	0.49	5.45	-3.00	-1.04	-1.18	-1.83	-1.98	-3.27	-3.03	-6.81
Net Debt to NOPAT	-1.81	-2.19	-20.31	11.86	4.19	4.49	6.82	9.75	18.60	17.60	35.98
Long-Term Debt to NOPAT	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Altman Z-Score	4.54	5.14	4.41	3.92	4.24	3.57	3.58	3.59	4.44	3.63	3.23
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	2.65	3.01	3.12	3.45	3.32	2.98	3.05	3.08	3.05	2.97	3.13
Quick Ratio	1.48	1.62	1.48	1.67	1.67	1.62	1.82	1.98	2.02	2.05	2.25
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	0.16	-1.54	1.70	-0.37	-0.03	9.37	10	13	15	4.75	4.06
Operating Cash Flow to CapEx	910.10%	810.62%	-1,405.66%	464.23%	480.88%	21,709.09%	-1,610.00%	18,921.05%	256.90%	358.24%	-168.93%
Free Cash Flow to Firm to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	1.45	1.37	1.17	0.99	0.87	0.88	0.95	1.01	1.05	1.16	1.15
Accounts Receivable Turnover	5.99	6.12	4.92	4.98	4.74	5.31	5.43	6.59	7.58	8.00	5.84
Inventory Turnover	2.59	2.30	1.86	1.56	1.34	1.29	1.40	1.65	1.83	1.96	2.25
Fixed Asset Turnover	28.69	27.92	24.09	21.22	20.01	20.47	23.88	26.31	29.78	33.64	37.57
Accounts Payable Turnover	5.98	5.79	6.65	5.49	4.89	4.87	5.29	7.23	7.57	6.53	5.93
Days Sales Outstanding (DSO)	60.95	59.68	74.14	73.29	77.08	68.70	67.18	55.35	48.15	45.63	62.46
Days Inventory Outstanding (DIO)	141.14	158.81	196.72	234.47	272.02	282.64	260.46	221.72	199.35	186.32	162.55
Days Payable Outstanding (DPO)	61.01	63.05	54.85	66.44	74.70	74.99	68.99	50.48	48.21	55.91	61.55
Cash Conversion Cycle (CCC)	141.08	155.44	216.02	241.31	274.40	276.35	258.66	226.59	199.29	176.04	163.46
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	30	29	30	30	29	19	20	17	15	14	16
Invested Capital Turnover	2.63	2.53	1.94	1.78	1.57	1.79	1.83	2.08	2.28	3.13	2.92
Increase / (Decrease) in Invested Capital	0.84	1.18	-2.61	0.06	-0.56	-10	-10	-13	-15	-5.56	-3.32
Enterprise Value (EV)	55	59	44	29	39	30	26	22	38	23	18
Market Capitalization	64	70	52	38	49	41	37	37	55	40	34
Book Value per Share	$3.93	$3.96	$3.87	$3.85	$3.84	$3.06	$3.07	$3.10	$3.15	$3.08	$3.15
Tangible Book Value per Share	$3.66	$3.69	$3.60	$3.59	$3.57	$2.80	$2.81	$2.84	$2.76	$2.67	$2.70
Total Capital	41	42	41	41	41	34	34	34	35	34	35
Total Debt	2.25	2.25	2.25	2.25	2.25	3.00	3.00	3.00	3.00	3.00	3.00
Total Long-Term Debt	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Net Debt	-9.36	-10	-8.38	-8.88	-9.09	-11	-11	-15	-17	-17	-16
Capital Expenditures (CapEx)	0.10	0.11	0.11	0.14	0.07	0.01	0.01	0.02	1.41	0.17	0.56
Debt-free, Cash-free Net Working Capital (DFCFNWC)	17	17	18	17	17	14	15	12	9.29	8.33	11
Debt-free Net Working Capital (DFNWC)	29	30	29	29	28	28	29	30	29	29	29
Net Working Capital (NWC)	27	27	26	26	26	25	26	27	26	26	26
Net Nonoperating Expense (NNE)	0.10	-0.30	0.13	0.01	-0.03	7.22	-0.02	-0.04	-0.01	0.32	-0.02
Net Nonoperating Obligations (NNO)	-9.36	-10	-8.38	-8.88	-9.09	-11	-11	-15	-17	-17	-16
Total Depreciation and Amortization (D&A)	0.38	0.39	0.40	0.24	0.21	0.19	0.17	0.17	0.16	0.17	0.16
Debt-free, Cash-free Net Working Capital to Revenue	22.24%	23.81%	29.51%	33.02%	36.76%	32.46%	32.76%	25.15%	18.48%	16.18%	19.87%
Debt-free Net Working Capital to Revenue	37.25%	40.77%	46.93%	54.13%	61.19%	65.64%	63.75%	62.16%	58.36%	55.87%	55.53%
Net Working Capital to Revenue	34.34%	37.67%	43.24%	49.86%	56.35%	58.73%	57.19%	55.90%	52.39%	50.04%	49.85%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.09	($0.01)	($0.10)	($0.03)	($0.06)	($0.80)	$0.00	($0.01)	$0.00	($0.11)	$0.08
Adjusted Weighted Average Basic Shares Outstanding	9.96M	9.95M	9.97M	10.00M	10.01M	10.00M	10.04M	10.09M	10.10M	10.09M	10.18M
Adjusted Diluted Earnings per Share	$0.09	($0.01)	($0.10)	($0.03)	($0.06)	($0.80)	$0.00	($0.01)	$0.00	($0.11)	$0.07
Adjusted Weighted Average Diluted Shares Outstanding	10.05M	10.02M	9.97M	10.00M	10.01M	10.00M	10.05M	10.09M	10.16M	10.09M	10.23M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	9.96M	9.96M	9.99M	10.00M	10.01M	10.08M	10.08M	10.09M	10.11M	10.24M	10.28M
Normalized Net Operating Profit after Tax (NOPAT)	1.00	-0.37	-0.91	-0.31	-0.59	-0.74	-0.01	-0.18	0.01	-0.81	0.75
Normalized NOPAT Margin	5.84%	-2.75%	-8.52%	-2.64%	-5.39%	-7.18%	-0.08%	-1.31%	0.07%	-7.07%	5.19%
Pre Tax Income Margin	6.25%	-0.72%	-12.29%	-3.49%	-6.43%	-11.25%	0.54%	-0.75%	0.30%	-9.53%	5.47%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
EBIT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Financials Breakdown Chart

TransAct Technologies Financials - Frequently Asked Questions

According to the most recent income statement we have on file, TransAct Technologies' financial year ends in December. Their financial year 2025 ended on December 31, 2025.

TransAct Technologies' net income appears to be on an upward trend, with a most recent value of -$1.24 million in 2025, falling from $3.09 million in 2015. The previous period was -$9.86 million in 2024. See where experts think TransAct Technologies is headed by visiting TransAct Technologies' forecast page.

TransAct Technologies' total operating income in 2025 was -$1.42 million, based on the following breakdown:

Total Gross Profit: $25.02 million
Total Operating Expenses: $26.43 million

Over the last 10 years, TransAct Technologies' total revenue changed from $59.68 million in 2015 to $51.48 million in 2025, a change of -13.7%.

TransAct Technologies' total liabilities were at $13.65 million at the end of 2025, a 1.9% increase from 2024, and a 99.6% increase since 2015.

In the past 10 years, TransAct Technologies' cash and equivalents has ranged from $2.50 million in 2016 to $20.43 million in 2025, and is currently $20.43 million as of their latest financial filing in 2025.

Over the last 10 years, TransAct Technologies' book value per share changed from 3.29 in 2015 to 3.08 in 2025, a change of -6.5%.

Related Companies

Financial statements for NASDAQ:TACT last updated on 7/16/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

TransAct Technologies (TACT) Financials

Financials Breakdown Chart

TransAct Technologies Financials - Frequently Asked Questions

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

TransAct Technologies (TACT) Financials

Annual Income Statements for TransAct Technologies

Quarterly Income Statements for TransAct Technologies

Annual Cash Flow Statements for TransAct Technologies

Quarterly Cash Flow Statements for TransAct Technologies

Annual Balance Sheets for TransAct Technologies

Quarterly Balance Sheets for TransAct Technologies

Annual Metrics And Ratios for TransAct Technologies

Quarterly Metrics And Ratios for TransAct Technologies

Financials Breakdown Chart

TransAct Technologies Financials - Frequently Asked Questions

When does TransAct Technologies' fiscal year end?

How has TransAct Technologies' net income changed over the last 10 years?

What is TransAct Technologies' operating income?

How has TransAct Technologies' revenue changed over the last 10 years?

How much debt does TransAct Technologies have?

How much cash does TransAct Technologies have?

How has TransAct Technologies' book value per share changed over the last 10 years?

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools